Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Amber Rathor's publication output changed over time?
ScholarIQpublication output · 2021–2026
Output grew0% over the shown period — from 1 works in 2021 to 1 in 2026.
1
1
2
3
1
20212023202420252026
What are the most-cited papers on Amber Rathor?
ScholarIQmost cited works
Mapping the immune landscape in small cell lung cancer by analysing expression of immuno-modulators in tissue biopsies and paired blood samples
Rimlee Dutta, Amber Rathor, Hanuman Prasad Sharma, Hem Chandra Pandey, Prabhat Singh Malik, Anant Mohan, Aruna Nambirajan, Rajeev Kumar, Deepali Jain
Scientific Reports. 202311 CitationsOPEN ACCESS
Pleural effusion supernatant: a reliable resource for cell-free DNA in molecular testing of lung cancer
Shilpi Thakur, Amber Rathor, Surabhi Jain, Surabhi Jain, Aruna Nambirajan, Sachin Khurana, Prabhat Singh Malik, Deepali Jain
S2765000471. 20245 Citations
‘Plasma first’ approach for detecting epidermal growth factor receptor mutation in advanced non-small cell lung carcinoma
Amber Rathor, Prabhat Singh Malik, Pranay Tanwar, Sachin Khurana, Hemavathi Baskarane, Deepam Pushpam, Aruna Nambirajan, Deepali Jain
Journal of Cancer Research and Clinical Oncology. 20245 CitationsOPEN ACCESS
From bench to bedside and beyond: Challenges in direct KRAS targeting
Atish Gheware, Amber Rathor, Deepali Jain
S4210179561. 20213 CitationsOPEN ACCESS
Baseline retinoblastoma transcriptional corepressor 1 (Rb1) functional inactivation is a pre-requisite but not sufficient for small-cell histological transformation in epidermal growth factor receptor (EGFR) mutant lung adenocarcinomas post-tyrosine kinase inhibitor therapy
Aruna Nambirajan, Amber Rathor, Hemavathi Baskarane, Anju Gs, Sachin Khurana, S. Sushmitha, Aparna Sharma, Prabhat Singh Malik, Deepali Jain
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 20252 Citations
Related on ScholarIQ
All India Institute of Medical Sciences
Institution
Mapping the immune landscape in small cell lung cancer by analysing expression of immuno-modulators in tissue biopsies and paired blood samples
Paper
Pleural effusion supernatant: a reliable resource for cell-free DNA in molecular testing of lung cancer
Paper
‘Plasma first’ approach for detecting epidermal growth factor receptor mutation in advanced non-small cell lung carcinoma
Paper
From bench to bedside and beyond: Challenges in direct KRAS targeting
Paper
Baseline retinoblastoma transcriptional corepressor 1 (Rb1) functional inactivation is a pre-requisite but not sufficient for small-cell histological transformation in epidermal growth factor receptor (EGFR) mutant lung adenocarcinomas post-tyrosine kinase inhibitor therapy
Paper